ARROWHEAD PHARMACEUTICALS, INC.

Develops RNAi medicines to silence genes causing intractable cardiometabolic and pulmonary diseases.

ARWR | US

Overview

Corporate Details

ISIN(s):: US04280A1007
LEI:
Country:: United States of America
Address:: 177 E COLORADO BLVD, 91105 PASADENA
Website:: https://arrowheadpharma.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company's core technology is its proprietary Targeted RNAi Molecule (TRiM™) platform, which utilizes RNA interference (RNAi) to induce rapid, deep, and durable suppression of specific target genes. Arrowhead's clinical pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases, such as hepatitis B and alpha-1 antitrypsin deficiency-associated liver disease. The company emphasizes accelerating the development of its innovative therapies from discovery to the clinic to address unmet patient needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ARROWHEAD PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ARROWHEAD PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ARROWHEAD PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Inhibikase Therapeutics, Inc. Develops kinase inhibitors to treat neurodegenerative diseases like Parkinson's.	United States of America	IKT
Inhibrx Biosciences, Inc. Clinical-stage biopharma developing novel biologic therapies for life-threatening cancers.	United States of America	INBX
InMed Pharmaceuticals Inc. Develops cannabinoid drugs for unmet medical needs and supplies rare cannabinoids for B2B wellness.	United States of America	INM
Inmune Bio, Inc. Develops immunotherapies reprogramming innate immunity for cancer, Alzheimer's, and inflammation.	United States of America	INMB
Innate Pharma SA Developing first-in-class antibody immunotherapies for cancer via the innate immune system.	United States of America	IPHA
INOVIO PHARMACEUTICALS, INC. Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.	United States of America	INO
Insight Molecular Diagnostics Inc. Develops molecular diagnostic tests for oncology and transplant monitoring for clinicians & researchers.	United States of America	IMDX
INSMED Inc Develops and commercializes innovative therapies for serious and rare diseases.	United States of America	INSM
Instil Bio, Inc. Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.	United States of America	TIL
Intellia Therapeutics, Inc. Developing curative CRISPR/Cas9 genome editing therapies for severe genetic disorders.	United States of America	NTLA